Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral bacterial metabolic enzymes are a heterogeneous group of proteins produced by the oral microbiome that facilitate essential life processes and contribute to the pathogenesis of dental diseases. These enzymes include glucosyltransferases (GTFs), which synthesize extracellular polysaccharides from dietary sucrose to form the dental plaque matrix, and glycolytic enzymes like enolase, which catalyze the production of lactic acid leading to enamel demineralization [Bowen & Koo, 2011; Marquis et al., 2003]. Additionally, proteolytic enzymes such as gingipains from Porphyromonas gingivalis are involved in the degradation of host tissues and immune evasion in periodontal disease [Potempa et al., 2003]. Therapeutic strategies often target these enzymes to disrupt biofilm integrity or reduce acidogenicity; for instance, fluoride ions directly inhibit enolase activity, while xylitol acts as a competitive inhibitor of bacterial sugar transport systems [Takahashi & Washio, 2011]. Beyond oral health, the metabolic activity of these enzymes is linked to systemic inflammation and chronic conditions like cardiovascular disease, making them significant targets for both local and systemic health management [Hajishengallis, 2015].
Inhibition of glycolytic enzymes (e.g., enolase), disruption of glucosyltransferase-mediated biofilm synthesis, and competitive inhibition of sugar transport systems.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral bacterial metabolic enzymes.